Methyl 4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]benzoate

Catalog No.: 
ACNGDQ143
CAS No.: 
254911-05-2
Molecular Formula: 
C17H12ClNO2S
Molecular Weight: 
329.81
Methyl 4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%
1g90%
5g90%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]benzoate
IUPAC Namemethyl 4-(4-(4-chlorophenyl)thiazol-2-yl)benzoate
MDL No.MFCD00171793
Molecular FormulaC17H12ClNO2S
Molecular Weight329.81
SMILESO=C(OC)C1=CC=C(C2=NC(C3=CC=C(Cl)C=C3)=CS2)C=C1
InChI KeySETZBWRFOSVMDE-UHFFFAOYSA-N
SynonymMETHYL 4-[4-(4-CHLOROPHENYL)-1,3-THIAZOL-2-YL]BENZENECARBOXYLATE;methyl 4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]benzoate;Benzoic acid, 4-[4-(4-chlorophenyl)-2-thiazolyl]-, methyl ester
CAS No.254911-05-2

Synthetic Route by SureRoute

1. ACNGDQ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJFUR897 route compound structure diagram
    ACJFUR89780393-38-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGDQ143 route product structure diagram
    ACNGDQ143254911-05-2
Inquiry

2. ACNGDQ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJFUR897 route compound structure diagram
    ACJFUR89780393-38-0In Stock
  2. Plus
  3. ACPWEN473 route compound structure diagram
    ACPWEN473937-20-2In Stock
  4. Then
  5. ACNGDQ143 route product structure diagram
    ACNGDQ143254911-05-2
Inquiry

3. ACNGDQ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBOVU410 route compound structure diagram
    ACBOVU41099768-12-4In Stock
  2. Plus
  3. ACFCZG620 route compound structure diagram
    ACFCZG62039564-86-8In Stock
  4. Then
  5. ACNGDQ143 route product structure diagram
    ACNGDQ143254911-05-2
Inquiry

Comments (0)